![David Shen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Shen
Algemeen Directeur bij Proteologix US, Inc.
Actieve functies van David Shen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Proteologix US, Inc.
![]() Proteologix US, Inc. BiotechnologyHealth Technology Proteologix US, Inc. is based in Redwood City, CA. Part of Johnson & Johnson, Proteologix US, Inc. is a biopharmaceutical company. The CEO of the company is David Wenyan Shen. Proteologix US was acquired by Johnson & Johnson on June 21, 2024 for $850 million. | Algemeen Directeur | - | - |
Voorzitter | - | - | |
Financieel Directeur/CFO | - | - | |
Bedrijfssecretaris | - | - |
Loopbaan van David Shen
Eerdere bekende functies van David Shen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
NGM BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | - | 01-07-2021 |
GlycoFi, Inc.
![]() GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Corporate Officer/Principal | - | - |
Merck, Inc. | Corporate Officer/Principal | - | - |
Teva Pharmaceuticals USA, Inc.
![]() Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | - | - |
Opleiding van David Shen
East China University of Science & Technology | Undergraduate Degree |
University of Toronto | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
China | 2 |
Canada | 2 |
Operationeel
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NGM BIOPHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Teva Pharmaceuticals USA, Inc.
![]() Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
Merck, Inc. | |
GlycoFi, Inc.
![]() GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Health Technology |
Proteologix US, Inc.
![]() Proteologix US, Inc. BiotechnologyHealth Technology Proteologix US, Inc. is based in Redwood City, CA. Part of Johnson & Johnson, Proteologix US, Inc. is a biopharmaceutical company. The CEO of the company is David Wenyan Shen. Proteologix US was acquired by Johnson & Johnson on June 21, 2024 for $850 million. | Health Technology |
- Beurs
- Insiders
- David Shen
- Ervaring